Los Angeles Capital Management LLC Has $10.46 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Los Angeles Capital Management LLC lifted its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 59.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 93,540 shares of the financial services provider's stock after purchasing an additional 34,959 shares during the period. Los Angeles Capital Management LLC's holdings in Aflac were worth $10,458,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Y.D. More Investments Ltd acquired a new stake in shares of Aflac during the 2nd quarter worth about $25,000. Covestor Ltd increased its stake in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock worth $41,000 after purchasing an additional 107 shares during the period. Cedar Wealth Management LLC acquired a new stake in Aflac during the 1st quarter worth approximately $50,000. Catalyst Capital Advisors LLC bought a new stake in Aflac in the 3rd quarter valued at $51,000. Finally, Fairscale Capital LLC acquired a new position in Aflac in the 2nd quarter valued at $54,000. Institutional investors own 67.44% of the company's stock.

Aflac Trading Up 0.3 %

Shares of NYSE:AFL traded up $0.34 during mid-day trading on Tuesday, reaching $110.77. 508,512 shares of the company were exchanged, compared to its average volume of 2,228,132. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.10. The firm's 50-day simple moving average is $110.33 and its 200 day simple moving average is $98.95. The firm has a market cap of $61.54 billion, a price-to-earnings ratio of 16.63, a P/E/G ratio of 2.10 and a beta of 0.96. Aflac Incorporated has a 1 year low of $75.07 and a 1 year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. Aflac's revenue was down 40.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.84 EPS. Equities research analysts forecast that Aflac Incorporated will post 7.17 EPS for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac's dividend payout ratio is 30.12%.

Analysts Set New Price Targets

AFL has been the subject of a number of analyst reports. Citigroup lifted their price target on shares of Aflac from $84.00 to $93.00 and gave the company a "neutral" rating in a research report on Tuesday, July 23rd. UBS Group increased their target price on Aflac from $84.00 to $109.00 and gave the stock a "neutral" rating in a report on Wednesday, August 14th. Piper Sandler upped their price objective on shares of Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. TD Cowen began coverage on shares of Aflac in a report on Wednesday, October 9th. They issued a "hold" rating and a $102.00 target price on the stock. Finally, JPMorgan Chase & Co. increased their price target on shares of Aflac from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Thursday, October 3rd. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.